Shanghai Kehua Bio-Engineering Co Ltd (002022) — Financial Flexibility Index
Shanghai Kehua Bio-Engineering Co Ltd (002022) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥59.49 Million (operating CF CN¥28.25 Million minus capex CN¥31.24 Million) represents 0% of total liabilities (CN¥1.47 Billion). Check how strategically is Shanghai Kehua Bio-Engineering Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Kehua Bio-Engineering Co Ltd Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Shanghai Kehua Bio-Engineering Co Ltd across 24 annual periods. See 002022 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Shanghai Kehua Bio-Engineering Co Ltd (2002–2025)
Year-by-year free cash flow to debt coverage for Shanghai Kehua Bio-Engineering Co Ltd. For the full company profile including market capitalisation, see 002022 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.11x | CN¥161.73 Million | CN¥22.44 Million | CN¥1.53 Billion | ▼ -35.3% |
| 2024 | 0.16x | CN¥204.70 Million | CN¥-50.12 Million | CN¥1.25 Billion | ▲ +306.8% |
| 2023 | -0.08x | CN¥-143.97 Million | CN¥-474.89 Million | CN¥1.82 Billion | ▼ -109.1% |
| 2022 | 0.87x | CN¥2.58 Billion | CN¥2.15 Billion | CN¥2.96 Billion | ▲ +22.8% |
| 2021 | 0.71x | CN¥1.30 Billion | CN¥1.08 Billion | CN¥1.82 Billion | ▼ -9.2% |
| 2020 | 0.78x | CN¥1.62 Billion | CN¥1.37 Billion | CN¥2.08 Billion | ▲ +103.8% |
| 2019 | 0.38x | CN¥389.08 Million | CN¥248.87 Million | CN¥1.01 Billion | ▲ +64.2% |
| 2018 | 0.23x | CN¥250.77 Million | CN¥126.79 Million | CN¥1.07 Billion | ▼ -37.0% |
| 2017 | 0.37x | CN¥235.83 Million | CN¥130.71 Million | CN¥636.48 Million | ▼ -59.3% |
| 2016 | 0.91x | CN¥384.50 Million | CN¥281.25 Million | CN¥422.47 Million | ▲ +1.6% |
| 2015 | 0.90x | CN¥309.92 Million | CN¥224.30 Million | CN¥345.97 Million | ▼ -58.7% |
| 2014 | 2.17x | CN¥350.30 Million | CN¥249.64 Million | CN¥161.39 Million | ▲ +4.5% |
| 2013 | 2.08x | CN¥336.60 Million | CN¥250.22 Million | CN¥162.08 Million | ▲ +44.2% |
| 2012 | 1.44x | CN¥286.72 Million | CN¥213.74 Million | CN¥199.05 Million | ▼ -13.1% |
| 2011 | 1.66x | CN¥291.45 Million | CN¥219.80 Million | CN¥175.89 Million | ▼ -7.8% |
| 2010 | 1.80x | CN¥279.74 Million | CN¥241.83 Million | CN¥155.58 Million | ▼ -7.7% |
| 2009 | 1.95x | CN¥259.21 Million | CN¥217.51 Million | CN¥133.03 Million | ▲ +17.3% |
| 2008 | 1.66x | CN¥155.36 Million | CN¥137.66 Million | CN¥93.56 Million | ▲ +60.2% |
| 2007 | 1.04x | CN¥130.74 Million | CN¥112.93 Million | CN¥126.16 Million | ▼ -20.2% |
| 2006 | 1.30x | CN¥112.29 Million | CN¥87.21 Million | CN¥86.46 Million | ▲ +12.8% |
| 2005 | 1.15x | CN¥87.89 Million | CN¥73.97 Million | CN¥76.32 Million | ▼ -21.7% |
| 2004 | 1.47x | CN¥93.43 Million | CN¥48.74 Million | CN¥63.51 Million | ▲ +26.9% |
| 2003 | 1.16x | CN¥95.42 Million | CN¥70.57 Million | CN¥82.31 Million | ▲ +48.2% |
| 2002 | 0.78x | CN¥62.04 Million | CN¥41.48 Million | CN¥79.29 Million | — |